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Allogeneic BM transplantation (BMT) is an 
important treatment for hematological malig-
nancies. The therapeutic potential of BMT re-
lies on a graft-versus-leukemia (GVL) eff  ect in 
which donor T cells eradicate tumor cells ex-
pressing host or tumor-associated antigens. 
Unfortunately, the GVL response is frequently 
associated with the development of graft-ver-
sus-host disease (GVHD). An understanding of 
the mechanisms that lead to GVHD is critical 
for optimizing this therapeutic modality.
The induction of GVHD requires the re-
cruitment of eff  ector T cells to peripheral tis-
sues (1). After their transfer to freshly irradiated 
allogeneic recipients, naive donor T cells are 
initially retained within secondary lymphoid 
tissues (2). Here, they are activated by host 
APCs and undergo a rapid burst of prolifera-
tion (3, 4). After an interval of 3–4 d, large 
numbers of lymphoblasts enter the peripheral 
circulation and then exit to nonlymphoid tis-
sues such as the skin and gut (2, 5, 6), where 
they induce the profound tissue injury that 
characterizes GVHD.
It is well established that T cell activation 
leads to increased tropism for nonlymphoid tis-
sues (7, 8) and changes in traffi   cking potential 
are likely to be an important prerequisite for 
the recruitment of graft-versus-host (GVH-re-
active) T cells to peripheral tissues (1). How-
ever, it is not known whether such changes are 
suffi   cient for the induction of GVHD. Indeed, 
T cell reactivity against antigens expressed by 
the host does not automatically lead to tissue 
injury. For example, a state of “adaptive toler-
ance” in which rapid T cell proliferation is fol-
lowed by an eventual state of unresponsiveness 
is observed in several model systems after trans-
fer of transgenic T cells to hosts that ubiq-
uitously express antigens recognized by the 
relevant TCR (for review see reference 9). 
In some cases, there is a lack of tissue destruc-
tion despite the marked infi  ltration of target 
organs by activated T cells (10, 11).
 Importantly, T cell reactivity against host 
antigens may also be dissociated from damage 
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to peripheral tissues under circumstances in which T cells are 
not tolerant. For example,   although central, deletional toler-
ance to donor and recipient antigens is induced in established 
mixed chimeras (MCs; in which hematopoietic elements of 
both the donor and allogeneic recipient coexist) (12, 13), this 
state can readily be broken after the delayed transfer of naive, 
nontolerant donor T cells (14). In this situation, donor T cells 
induce a GVH reaction that eradicates normal and malignant 
host hematopoietic cells, but do so without inducing GVHD 
(14–16). In clinical studies, delayed transfer of T cells to allo-
geneic chimeras is also associated with a low risk of GVHD 
(17). The precise mechanisms underlying the lack of GVHD 
are not known but may relate to the resolution of the early 
infl  ammatory cascade induced by the conditioning protocol 
(18, 19). In this regard, nonmyeloablative protocols that gen-
erate low levels of tissue injury are associated with a reduced 
incidence of GVHD as compared with that observed after 
myeloablative conditioning (20).
To determine the role of infl  ammation in the develop-
ment of GVHD, we examined the behavior of T cells after 
transfer to allogeneic recipients under various conditions. We 
fi  rst demonstrate that diminished alloreactivity does not ex-
plain the failure of donor leukocyte infusion (DLI)-derived 
T cells to induce GVHD in established MCs. Instead, there is 
marked clonal expansion of GVH-reactive T cells, which de-
spite their presence within the peripheral circulation, fail to 
accumulate in skin or gut. This failure is not an intrinsic, ab-
solute defi  ciency in skin or gut tropism because the cells 
  induce severe GVHD after transfer to secondary, freshly irra-
diated recipients. Thus, recruitment of activated T cells to 
nonlymphoid organs is subject to tight regulation by T cell–
extrinsic factors within the host. Finally, we demonstrate 
here a critical role for local infl  ammation in permitting entry 
of activated T cells to a GVHD target tissue.
RESULTS
Recruitment of alloreactive T cells to peripheral tissues 
depends upon the host environment
Transfer of small numbers of T cells on day 0 to freshly irradi-
ated allogeneic recipients leads to severe, lethal GVHD. In 
contrast, when large numbers of T cells are transferred as de-
layed DLIs to established MCs, a GVH reaction occurs that 
eradicates host hematopoietic elements but does not lead to 
signifi  cant GVHD (14, 16). We fi  rst considered the possibil-
ity that intrinsic properties of alloreactive T cells are diff  erent 
in the two situations. To compare the donor T cell response 
elicited in these two contexts, we transferred 106 purifi  ed 
CD8+ T cells from 2C transgenic mice together with 107 B6 
CD45.1 donor splenocytes to established B6 CD45.2 + 
BALB/c→BALB/c MCs or to freshly irradiated BALB/c 
mice. The latter group of mice also received T cell–depleted 
(TCD) B6 BM to prevent death from marrow aplasia. 2C 
mice are transgenic for a high-affi   nity TCR that recognizes 
the Ld MHC class I alloantigen (21) expressed by the recipi-
ent strain. B6 splenocytes containing additional polyclonal 
B6 T cells were cotransferred to both groups to provide CD4 
help, which is required for full expansion and/or survival of 
the transgenic CD8+ T cells (22, 23) and to provide poly-
clonal CD8+ T cells. Thus, 2C CD8+ T cells were used as 
a known GVH-reactive marker population in the context of 
a “normal” GVH reaction.
As expected, lethally irradiated mice receiving allogeneic 
T cells on day 0 developed severe, lethal GVHD characterized 
by histological evidence of severe colitis (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20060376/DC1).
In contrast, when these T cells were administered to es-
tablished MCs, mice did not develop clinical GVHD and 
no histological evidence of colitis was observed at day 
10 or thereafter. Skin of freshly irradiated mice also showed 
evidence of GVHD, whereas that from MCs did not (not 
depicted). MCs did, however, show sustained increases in 
donor chimerism, consistent with a donor T cell–mediated 
lymphohematopoietic GVH reaction (Fig. S1). Irradiated, 
syngeneic control mice, as expected, did not develop GVHD 
(not depicted).
We next examined T cell proliferation and tissue accu-
mulation in these models. In both freshly irradiated mice and 
established MCs, we observed rapid proliferation (as evalu-
ated by CFSE dilution) of the transferred 2C CD8+ T cells 
within the recipient spleens (Fig. 1 A) and lymph nodes (not 
depicted). By day 6 after transfer to established MCs or 
freshly irradiated recipients, the proportion of the splenic 2C 
CD8+ T cell population that had undergone seven or more 
divisions was 90.6 ± 1.9% and 99.4 ± 0.2%, respectively. In 
contrast, by day 6, only 7–8% of 2C CD8+ T cells had un-
dergone seven or more divisions after transfer to freshly irra-
diated syngeneic recipients (Fig. 1 A). We evaluated tissue 
accumulation by measuring absolute numbers of 2C CD8+ 
T cells in the spleen, lymph nodes, blood, BM, and the in-
tra-epithelial compartment of the small and large intestine at 
timed intervals after transfer to the two cohorts of allogeneic 
recipient mice (Fig. 1, B–E, and not depicted). In the freshly 
irradiated mice, increased numbers of 2C CD8+ T cells were 
observed in the spleen, lymph nodes, BM, peripheral circu-
lation, and the intra-epithelial compartment of the intestine, 
peaking at  3–6 d after transfer (Fig. 1, B–E, and not de-
picted). In the MCs, there was a delayed but dramatic in-
crease in the numbers of 2C CD8+ T cells in the spleen, 
peaking at  12 d after transfer (Fig. 1 B), with less expansion 
evident within the lymph nodes and BM (Fig. 1 C and not 
depicted). However, despite the presence of similar peak 
numbers within the peripheral circulation in these two 
groups (Fig. 1 D), 2C CD8+ T cells failed to accumulate 
within the intra-epithelial compartment of the gut in MCs 
(Fig. 1 E). Similarly, polyclonal donor CD4+ and CD8+ 
T cells failed to accumulate in the intestines of established 
MCs, whereas large numbers of these cells were present in 
the intestines of freshly irradiated mice  (not depicted). Only 
limited accumulations of 2C CD8+ T cells occurred in the 
spleens and lymph nodes of freshly irradiated syngeneic con-
trol mice, but no signifi   cant accumulation was observed 
in the gut (Fig. 1, B, C, and E).JEM VOL. 203, August 7, 2006  2023
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The failure of GVH-reactive T cells to accumulate within 
GVHD target organs of established MC recipients could 
  refl  ect either a reduced capacity of stimulated T cells to traffi   c 
to these sites or, alternatively, a failure of these cells to survive, 
proliferate, or be retained in these locations. To evaluate 
the role of traffi   cking, we fi  rst measured the expression of 
homing markers on splenic 2C CD8+ T cells from each 
group. Consistent with their activation in vivo, 2C CD8+ 
T cells derived from the spleens of mice in the two groups 
expressed a broadly similar CD44highCD62L− CD45RBlow 
CD27high phenotype by day 12, although there were diff  er-
ences in the kinetics with which this phenotype was acquired 
(Fig. 1 F and not depicted). In contrast, after transfer to syn-
geneic controls, 2C CD8+ T cells showed only moderate up-
regulation of CD44 and transient, partial down-regulation of 
CD62L, consistent with the eff  ects of lymphopenia-  induced 
proliferation (24, 25). At the transcriptional level, we observed 
equivalent reductions in CCR7 expression in 2C CD8+ 
T cells after transfer to freshly irradiated mice and   established 
MCs as compared with naive cells (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20060376/DC1). 
Furthermore, although there were minor diff  erences between 
the two groups, 2C CD8+ T cell expression of the eff  ector 
cell–associated chemokine receptor CXCR3 increased sub-
stantially in both groups compared with naive cells (Fig. S2). 
To examine whether “imprinting” mediated by intestinal 
DCs (26–28) was diff  erent between the two groups, we com-
pared expression of the small intestinal homing receptor α4β7 
on 2C CD8+ T cells within meseneteric lymph nodes after 
transfer. The levels of α4β7 expression were similar in 2C 
CD8+ T cells derived from mesenteric lymph nodes in both 
groups, and these levels were higher than those observed in 
naive T cells (Fig. S2). Thus, activated GVH-reactive T cells 
in both groups modifi  ed their expression of homing receptors 
to a similar extent.
We obtained very similar fi   ndings in another recipi-
ent (BDF1) and donor (B6) strain combination. Thus, 2C
CD8+ T cells underwent similar activation and expansion 
Figure 1.  Distribution of antihost CD8+ CTLs between lymphoid 
and nonlymphoid tissues differs according to host environment. 
(A) Proliferation of transferred 2C CD8+ T cells as evaluated by CFSE 
  dilution. Dot plots showing CFSE staining (x axis) versus staining with 
the clonotypic marker 1B2 (y axis) in gated CD8+ T cells derived from 
recipient spleen on day +6 after transfer to established MCs (MC), 
freshly irradiated allogeneic recipients (TBI allo), or syngeneic recipients 
(TBI syn). Note that the CFSE+1B2− population represents polyclonal 
CFSE-labeled B6 CD8+ T cells that were cotransferred. (B–E) Absolute 
numbers expressed as mean ± SEM (n = 3 mice per group, except syn-
geneic mice, which comprised 1–2 mice per group) of antihost 2C trans-
genic CD8+ CTLs in the spleen (B), lymph nodes (C), peripheral blood 
(D), and intra-epithelial compartment of the intestine (E) after DLIs on 
day 0 to freshly irradiated allogeneic (○) or syngeneic mice (□), or to 
established MCs (■). Data shown in A–E are one of three independent 
experiments performed, which had similar results. Peripheral blood enu-
meration was not performed in syngeneic control mice. (F) Mean per-
centage (±SEM) of antihost 2C transgenic CD8+ CTLs in the spleen that 
were CD44high and CD62L+ after DLIs to MCs (■) and freshly irradiated 
allogeneic (○) or syngeneic mice (□). Data are representative of one out 
of three independent experiments.2024  INFLAMMATION REGULATES RECRUITMENT OF T CELLS TO TISSUES | Chakraverty et al.
in the spleens of B6 + BDF1→BDF1 MCs and freshly 
  irradiated BDF1 mice (Fig. S3, which is available at 
http://www.jem.org/cgi/content/full/jem.20060376/DC1, 
and not depicted). In both groups, 2C CD8+ T cells expressed 
a broadly similar CD44high CD45RBlow CD62L− phenotype 
(not depicted). As for the BALB/c recipient and B6 donor 
combination, there was a complete absence of donor T cell 
accumulation within the gut of MCs and these recipients did 
not develop colitis (Fig. S3 and not depicted). Furthermore, 
similar expansions of donor T cells after DLIs were observed 
in MCs prepared with nonmyeloablative conditioning and 
those generated after lethal irradiation and reconstitution 
with donor and recipient TCD BM (not depicted).
To examine the traffi   cking of donor T cells to GVHD 
target tissues directly, we used intravital microscopy of the 
skin. In MCs, T cell transfer does not induce GVHD within 
the skin, whereas it does so in freshly irradiated mice (not de-
picted). To examine traffi   cking, we transferred 4 × 106 puri-
fi  ed T cells derived from transgenic B6 GFP mice to freshly 
irradiated BDF1 mice or to established B6 + BDF1→BDF1 
MCs. On days 5 and 12 after transfer, the ear pinnae of sur-
viving recipient mice were imaged using two-photon mi-
croscopy. In freshly irradiated recipients, we observed marked 
accumulation of GFP+ T cells, particularly in relation to hair 
follicles (Fig. 2, A and C). In contrast, when these cells were 
transferred to established B6 + BDF1→BDF1 MCs, the 
numbers of GFP+ T cells accumulating within the skin were 
minimal (Fig. 2, B and D). To examine the behavior of 
T cells in real time, we used second harmonics to identify ves-
sels that corresponded in size to postcapillary venules and ob-
served the movement of GFP+ T cells within them. In freshly 
irradiated recipients, large numbers of GFP+ T cells demon-
strated sticking or rolling to postcapillary venule walls on day 
5 (Fig. 2 E and Video S1, which is available at http://www.
jem.org/cgi/content/full/jem.20060376/DC1). In contrast, 
when identical numbers of cells were transferred to estab-
lished B6 + BDF1→BDF1 MCs, the numbers of GFP+ 
T cells rolling or sticking to the vessel walls were minimal on 
days 5 and 12 (Fig. 2 F and Video S2), despite the presence 
of similar numbers of these cells in the peripheral circulation. 
Thus, after transfer to MCs, alloantigen-activated T cells un-
dergo marked clonal expansion and modify their expression 
of homing receptors but fail to enter nonlymphoid organs 
and induce GVHD.
T cells primed after transfer to established MCs induce 
GVHD in freshly irradiated recipients
The behavior of activated T cell populations depends on 
both intrinsic characteristics that develop during initial prim-
ing and on extrinsic factors within the postpriming environ-
ment (29). One possible explanation for the failure of 
GVH-reactive T cells to enter the peripheral tissues of estab-
lished MCs is that these cells have an intrinsic defect in tissue 
homing and/or function. To test this possibility, we trans-
ferred donor T cells activated in established MCs to second-
ary, lethally irradiated recipients (Fig. 3 A). Thus, 2.5 × 107 
B6 CD45.1 splenocytes were administered to established B6 
CD45.2 + BDF1→BDF1 MCs. By day 28 after transfer, 
  recipient mice demonstrated conversion to full donor chime-
rism, although none developed GVHD (Fig. 3 B). On day 12 
after transfer, we killed some of the recipient mice and sorted 
CD45.1+ T cells from the spleen by immunomagnetic selec-
tion (day 12 T cells). Day 12 was chosen because this time 
point corresponded to the peak of polyclonal donor CD4+ 
and CD8+ T cell expansion in this model (not depicted). We 
then transferred 2.5–4 × 106 purifi  ed day 12 T cells together 
with TCD B6 BM or TCD BM alone on day 0 to lethally 
  irradiated secondary BDF1 recipients. In two independent 
experiments, we observed that day 12 T cells induced severe 
clinical (Fig. 3 C) and histological (not depicted) GVHD 
upon transfer to lethally irradiated recipients. To exclude the 
possibility that small numbers of naive T cells present within 
the day 12 T cell population were responsible for inducing 
GVHD in  secondary recipients, we compared the eff  ect of 
transferring 2.5 × 106 similarly selected CD45.1+ naive T cells 
with that of 2.5 × 106 day 12 T cells. As expected, recipients 
of naive T cells developed clinical and histological evidence 
of GVHD (not depicted), but the median survival was >100 d 
versus only 31 d in recipients of day 12 T cells. Furthermore, 
because donor CD4+ T cells increase the severity of GVHD 
Figure 2.  Absence of donor T cells in skin after transfer to estab-
lished MCs. Representative images of skin (A and B, day 5) and mean ± 
SEM (n = 3 per group) number of GFP+ T cells per fi  eld (C and D) derived 
from two-photon imaging of recipient ear pinnae after transfer to freshly 
irradiated recipients (A and C) and MCs (B and D) *, P < 0.05 day 5 freshly 
irradiated mice versus MC. White arrows indicate hair follicles. Represen-
tative images of postcapillary venules imaged on day 5 after GFP+ T cell 
transfer to freshly irradiated recipients (E) or MCs (F). Freshly irradiated 
mice died before day 12 and therefore could not be assessed at this time 
point. ND, not done.JEM VOL. 203, August 7, 2006  2025
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in this model (30), it is noteworthy that day 12 T cells in-
duced accelerated GVHD despite   reduced numbers of donor 
CD4+ T cells being transferred compared with the naive in-
oculum (ratio CD4/CD8, 1:1 in day 12 T cells and 2:1 in 
naive T cells). These fi  ndings indicate that there is no abso-
lute intrinsic homing or functional defect in T cells activated 
after transfer to established MCs.
T cells from mice with GVHD fail to induce GVHD 
in established MCs
The data described above suggested that T cell–extrinsic fac-
tors in the host are crucial in regulating the capacity of GVH-
reactive T cells to induce GVHD. To further test this 
possibility, we performed the converse experiment in which 
T cells from freshly irradiated mice were transferred to estab-
lished MCs (Fig. 4 A). First, 107 B6 CD45.2 splenocytes and 
TCD B6 BM were transferred on day 0 to lethally irradiated 
B6DF1 recipient mice. This dose of splenocytes is suffi   cient 
to induce severe, lethal GVHD (not depicted). On day 4 after 
transfer, mice were killed and T cells from recipient spleens 
were purifi  ed by immunomagnetic selection. 2.5 × 106 day 
4 T cells (CD4/CD8 ratio, 3:1, refl  ecting their ratio in recip-
ient spleens) were then transferred either to freshly irradiated 
BDF1 mice or to established B6 CD45.2 + BDF1→BDF1 
MCs (Fig. 4 A). The former group of mice also received 
TCD B6 BM to prevent death from marrow aplasia. In three 
independent experiments, transfer of T cells from mice de-
veloping GVHD induced rapid lethality in irradiated recipi-
ents. In contrast, when these cells were transferred to 
established MCs, they caused no death, no clinical or histo-
logical GVHD, and no increases in the levels of donor chi-
merism (Fig. 4, B and C, and not depicted). Strikingly, donor 
T cells failed to engraft after transfer to secondary MC recipi-
ents as evaluated by fl  ow cytometry of peripheral blood, sug-
gesting that they failed to survive in this host environment. In 
parallel experiments in which B6 GFP+ T cells obtained from 
primary, irradiated BDF1 recipients were transferred to MCs, 
no GFP+ T cells were evident in the circulation by day 5 
  after transfer (not depicted). In contrast, GFP+ T cells were 
present in large numbers in the circulation of secondary, 
freshly irradiated recipients and showed evidence of rolling/
tethering in the postcapillary venules of recipient ear pinnae.
Localized Toll-like receptor (TLR) agonist triggers local 
GVHD following transfer of T cells to established MC
Collectively, the data in Figs. 3 and 4 indicate that T cell– ex-
trinsic factors regulate the capacity of activated T cells to in-
duce GVHD. However, the failure of day 4 eff  ector T cells 
to engraft in secondary MC recipients prevented a direct 
evaluation of the role of extrinsic factors on the homing of 
GVH-reactive T cells originally activated in the presence of 
infl  ammation. Thus, we adopted an alternative strategy in 
which we altered the extrinsic environment in MCs and 
evaluated its infl  uence upon the behavior of donor T cells. 
We fi  rst considered the possibility that infl  ammation such as 
that induced by innate immune activation would be required 
Figure 3.  T cells derived from MCs induce GVHD upon transfer to 
freshly irradiated recipients. (A) 2.5 × 107 naive B6 CD45.1 splenocytes 
were transferred to established B6 + BDF1→BDF1 MCs. On day 12, 
CD45.1+CD3+ T cells were sorted from recipient spleens and 2.5–4 × 106 
cells were transferred to secondary irradiated recipients. (B) Transfer of 
naive donor splenocytes (■) to MCs induces conversion to full donor 
chimerism (left) but not GVHD (right) as compared with untreated 
MCs (□). (C) Survival (left) and clinical GVHD scores (right) after transfer 
of 4 × 106 day 12 CD45.1+ T cells plus TCD donor BM (■; n = 6) or TCD 
BM alone (□; n = 7) to freshly irradiated secondary recipients. Data 
shows one of two independent experiments with similar results (survival 
comparison, P = 0.004 day 12 CD45.1+ T cells plus TCD donor BM vs. 
TCD BM alone).2026  INFLAMMATION REGULATES RECRUITMENT OF T CELLS TO TISSUES | Chakraverty et al.
to permit tissue entry of activated T cells. The early phase 
  after lethal irradiation is characterized by substantial activa-
tion of the innate immune system and systemic infl  ammation 
(31, 32). Therefore, we reasoned that induction of innate im-
mune activation via TLR ligation at the time of T cell trans-
fer to established MCs would generate conditions permissive 
for the induction of GVHD. To model the eff  ects of TLR 
triggering, we used a synthetic TLR7 agonist (an imidazo-
quinoline derivative, R-848), which induces substantial in-
nate immune activation in vivo (33). R-848 was administered 
to established MCs that either did or did not receive 3 × 107 
B6 splenocytes (Fig. 5 A). MCs receiving R-848 alone or 
3  × 107 donor splenocytes alone developed no signs of 
GVHD. In sharp contrast, MCs receiving both R-848 ago-
nist and donor splenocytes developed signifi  cant weight loss 
(Fig. 5 A), with histological evidence of GVHD at day +50 
aff  ecting the lung, liver, gut, and skin (not depicted). Thus, 
systemic exposure to a TLR agonist is suffi   cient to permit 
  access of activated T cells to peripheral tissues and the induc-
tion of GVHD.
Systemic activation of a TLR could promote GVHD in 
MCs by inducing infl  ammation in GVHD target tissues that 
promotes T cell recruitment or, alternatively, by altering the 
intrinsic character of T cells in the DLI, perhaps in part by 
overcoming the activity of regulatory T cells (34, 35). To dis-
tinguish among these possibilities, we next asked whether 
  local activation of the same TLR would induce local versus 
systemic GVHD. For this purpose, we applied imiquimod, an 
imidazoquinoline derivative that acts as a TLR7 agonist 
(33, 36), to localized skin areas of MCs receiving DLI. Im-
iquimod has previously been shown not to induce signifi  cant 
T cell recruitment in otherwise untreated mice (36). In this 
experiment, the ear pinnae of established MCs were painted 
with imiquimod at the time of transfer of 9 × 106 GFP+ do-
nor T cells. The extent of GFP+ T cell recruitment to the 
skin was then examined. As expected, only very minor infi  l-
tration of T cells was observed in imiquimod-treated controls 
given syngeneic T cells (Fig. 5, B and D). Likewise, MCs that 
were given donor T cells without imiquimod showed very 
little skin infi  ltration (Fig. 5, B and D). In contrast, massive 
skin infi  ltration of donor T cells was observed in imiquimod-
treated MCs, peaking on day 12 after transfer (Fig. 5, B and D). 
We used in vivo fl  ow cytometry as a means of evaluating the 
number of GFP+ T cells in the input arteriolar circulation. 
As shown in Fig. 5 C, no diff  erences were observed in the 
numbers of GFP+ cells in MCs treated or not treated with 
imiquimod, indicating that the level of donor T cell expan-
sion and circulation was similar  in both groups. In additional 
experiments (Fig. 5 E), we confi  rmed that local infl  ammation 
induced only local GVHD in imiquimod-treated MCs by 
treating the left fl  ank of recipient mice with agonist on days 
0 and 5 after T cell transfer and leaving the right fl  ank un-
treated. The mice developed unilateral GVHD in the treated 
skin and not in the skin of the untreated fl  ank. No GVHD 
was observed in similarly treated mice that did not receive 
donor T cells (Fig. 5 E). Thus, local infl  ammation was suffi   cient 
Figure 4.  T cells derived from mice developing GVHD are unable to 
induce GVHD upon transfer to MCs. (A) 107 naive B6 CD45.1 spleno-
cytes plus TCD BM were transferred to freshly irradiated BDF1 recipients. 
On day 4, CD3+ T cells were sorted from recipient spleens and 2.5 × 106 
cells were transferred to secondary irradiated BDF1 mice or to established 
B6 + BDF1→BDF1 MCs. (B) Survival and (C) clinical GVHD scores after 
transfer of 2.5 × 106 day 4 T cells plus TCD donor BM (●; n = 10) or TCD 
BM alone (○; n = 11) to freshly irradiated secondary recipients, or after 
transfer of day 4 T cells (■; n = 11) or nil (□; n = 8) to established MCs. 
Pooled data are shown from two independent experiments of the same 
design (P < 0.0001 survival comparison day 4 T cells plus TCD donor BM 
vs. each of three other groups).JEM VOL. 203, August 7, 2006  2027
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and necessary to permit local donor T cell recruitment and 
GVHD. Collectively, our data indicate that the presence of 
peripheral tissue infl  ammation through activation of the in-
nate immune response is a checkpoint of overriding impor-
tance in the recruitment of activated T cells.
DISCUSSION
After activation in secondary lymphoid tissues, T cells ac-
quire the ability to traffi   c to nonlymphoid organs (37, 38). 
Our studies have shown that there is an additional require-
ment for tissue infl  ammation to permit traffi   cking to periph-
eral tissues. Activation by host APCs in MCs (16, 39) leads to 
marked expansion of GVH-reactive T cells to an extent simi-
lar to that observed in freshly irradiated recipients. However, 
in established MCs, this response is confi  ned to the lympho-
hematopoietic system. Signifi  cantly, we have demonstrated 
that such GVH-reactive T cells are fully capable of causing 
GVHD when placed into an infl  amed host environment. 
Moreover, if localized skin infl  ammation is generated in MCs 
at the time of T cell transfer, localized GVHD is induced. Al-
though tissue infl  ammation has been shown to support T cell 
accumulation in other models (40–42), to our knowledge 
this is the fi  rst demonstration that tissue infl  ammation con-
trols the development of GVHD at the local level. This is also 
the fi  rst direct demonstration that tissue infl  ammation regu-
lates T cell accumulation in a parenchymal tissue by control-
ling T cell access to that tissue.
Although no intrinsic, absolute homing defi  ciency of 
T cells activated in established MCs was demonstrated, we 
have not excluded an incomplete intrinsic functional defect. 
In this context, we noted delayed kinetics of CD62L down-
regulation in the GVH-reactive CD8+ T cells after transfer to 
established MCs compared with freshly irradiated mice, a 
fi  nding that may refl  ect diff  erences in the initial levels of do-
nor T cell activation induced upon transfer to the two groups. 
However, preferential recirculation of activated T cells to 
secondary lymphoid organs is unlikely to be a major explana-
tion for the lack of GVHD in MCs because peak circulating 
numbers of GVH-reactive T cells were similar in freshly irra-
diated mice and established MCs receiving DLIs. Moreover, 
at the peak of the response, only a minor fraction of GVH-
reactive CD8+ T cells expressed CD62L in either group. 
“Reprogramming” of T cells by activated DCs (28) might 
change the recirculatory patterns of these cells upon transfer 
Figure 5.  Localized TLR-induced infl  ammation permits access to 
skin for activated T cells. (A) Mean ± SEM weight ratio of untreated 
MCs (□; n = 3) or at timed intervals in MCs after transfer of 3 × 107 
splenocytes alone (■; n = 7), 3 × 107 splenocytes plus 50 μg R-848 
(given as 12.5 μg by i.p. injections at 3-d intervals from day 0; ●; n = 7), 
or 50 μg R-848 alone (○; n = 4). (B) Mean ± SEM (n = 3 per group) 
number of GFP+ T cells per fi  eld at time intervals after transfer of 9 × 106 
GFP+ T cells to syngeneic control mice treated topically with imiquimod 
(●), to untreated MCs (□), or to imiquimod-treated MCs (■). *, P < 0.05 
days 8 and 12 treated versus untreated MCs. (C) In vivo fl  ow cytometry 
was used to examine the frequency of GFP+ T cells in the arteriolar 
  circulation of ear pinnae on day 12 after transfer of 9 × 106 GFP+ T cells 
to the above groups. (D) Representative images derived from two-photon 
imaging of recipient ear pinnae on day 12 after transfer of 9 × 106 
GFP+ donor T cells to B6 mice treated topically with imiquimod (left), 
to untreated MCs (middle), or to imiquimod-treated MCs (right). (E) The 
left flank was treated with imiquimod, and the right flank was left 
  untreated in MCs receiving (top) or not receiving (bottom) 3 × 107 
donor splenocytes. Representative images are shown of histology on 
day 14 after transfer.2028  INFLAMMATION REGULATES RECRUITMENT OF T CELLS TO TISSUES | Chakraverty et al.
to freshly irradiated recipients or in the presence of local tis-
sue infl  ammation and explain their new capacity to induce 
GVHD under such conditions. However, the local nature of 
the GVHD induced in the presence of local infl  ammation 
indicates that, even after such complete activation by fully 
activated APCs, the T cells do not gain access to noninfl  amed 
skin. Thus, imprinting by tissue-specifi  c APCs in MCs seems 
unlikely to be the primary explanation for the failure of 
GVH-reactive T cells to access peripheral tissues.
Major diff  erences between the environments in freshly 
irradiated recipients and established MCs include stimuli 
driving lymphopenia-induced proliferation, the extent of 
suppression mediated by regulatory cell populations, and the 
degree of direct tissue injury or tissue infl  ammation induced 
by irradiation. For example, the transfer of T cells to lympho-
penic hosts is associated with enhanced proliferation and the 
acquisition of some eff  ector functions (24, 25, 43, 44). How-
ever, this phenomenon does not appear to infl  uence traffi   ck-
ing because transfer of T cells to irradiated, lymphopenic 
syngeneic hosts did not lead to accumulation of these cells 
within the gut. Furthermore, we did not observe severe 
GVHD after transfer of polyclonal T cells to nonirradiated 
allogeneic RAG knockout mice, indicating that lymphope-
nia-associated proliferation is insuffi   cient to confer marked 
GVHD-inducing capacity of alloreactive T cells in the ab-
sence of tissue infl   ammation (unpublished data). Another 
possibility is that regulatory cell populations in MCs are im-
portant in preventing the access of activated T cells to GVHD 
target organs. This contrasts with the situation in freshly irra-
diated recipients, in which the integrity of host regulatory 
mechanisms may be severely compromised (34, 35, 45). 
However, because localized TLR-induced skin infl  amma-
tion led to localized T cell recruitment and tissue injury, we 
conclude that the presence of tissue infl  ammation is suffi   cient 
to override any regulatory infl  uences that may be present in 
established MCs.
Our data demonstrate that local tissue factors control the 
recruitment of and the development of tissue damage by 
GVH-reactive T cells activated under identical conditions. 
Confl  icting data have been obtained in less clinically relevant 
models regarding the role of local infl  ammation in causing 
T cell entry into peripheral tissues. Several recent studies in-
volving a model host antigen have shown that infl  ammation 
can convert autoreactivity into overt autoimmune disease 
(10, 46–49). However, memory T cells were shown to read-
ily   infi  ltrate noninfl  amed tissue in some of these studies (10, 11). 
Our data are consistent with an important role for innate im-
mune activation and infl  ammation through exposure to mi-
crobial products that act as TLR ligands in inducing T cell 
recruitment to nonlymphoid tissues. Importantly, we have 
demonstrated here that localized infl  ammation induced by a 
TLR agonist induces localized T cell accumulation and local-
ized T cell–induced injury, suggesting that this infl  ammatory 
checkpoint exists at the level of individual tissues. The pre-
cise mechanisms through which local TLR activation leads to 
the local accumulation of activated T cells within peripheral 
tissues remain to be determined. TLR7 activation can modu-
late endothelial–T cell interactions (50), T cell proliferation 
and cytokine production (51), and APC functions (33). Thus, 
a local TLR-mediated infl  ammatory response could poten-
tially modulate the recruitment of activated T cells by infl  u-
encing their initial access or their subsequent in situ proliferation,
retention, or survival.
Comparison of the behavior of T cells after transfer to 
freshly irradiated mice and established MCs indicates that one 
mechanism by which host conditioning infl  uences recruit-
ment of activated T cells to nonlymphoid tissues is at the 
level of access. Initial rolling and subsequent arrest of T cells 
upon the vascular endothelium of nonlymphoid tissues re-
quires sequential and cooperative interactions between endo-
thelial selectins, chemokines, integrins, and their respective 
ligands or receptors expressed by T cells (for review see 
reference 52). In this context, irradiation has been demon-
strated to induce up-regulation of E-selectin and intercellular 
adhesion molecule 1 on endothelial cells in vitro (53). Simi-
larly, experiments involving the transfer of syngeneic T cells 
to freshly irradiated recipients indicate that irradiation can in-
duce the early and transient up-regulation of certain infl  am-
matory chemokines and adhesion molecules (32, 54, 55) in 
nonlymphoid tissues. In contrast, up-regulated expression of 
these molecules by peripheral tissues is greater and sustained 
for longer periods after the transfer of allogeneic T cells to 
freshly irradiated recipients (32, 54, 55). These data suggest a 
model wherein infl  ammation induced by conditioning plays 
an important role in the initial recruitment of T cells, which 
induce an infl  ammatory cascade promoting further recruit-
ment of T cells to GVHD target organs. According to this 
concept, endothelial cell recovery from the initial eff  ects of 
conditioning may be an important determinant of the failure 
of activated T cells to roll or arrest on the vascular endothe-
lium of established MCs.
In summary, we have demonstrated that activation 
and clonal expansion of GVH-reactive T cells can be dissoci-
ated almost completely from their ability to access gut or 
skin. This dissociation refl  ects tight control by local tissue-
dependent factors rather than an absolute, intrinsic homing 
defect. Most signifi  cantly, the presence of infl  ammation 
within nonlymphoid tissues is a prerequisite for traffi   cking of 
GVH-reactive T cells to those specifi  c sites and the induction 
of GVHD. Thus, reducing the degree of tissue infl  ammation 
induced by conditioning protocols may be crucial in the de-
sign of strategies to prevent GVHD. The restriction of the 
GVH reaction to the spleen, lymph nodes, and BM after 
  delayed T cell transfer to MCs helps to explain the develop-
ment of protective immunity against leukemia and lymphoma 
cells that reside at the same location after DLI (15, 16, 39). 
It will be of interest to determine whether a local infl  amma-
tory response to tumor infi  ltration at these sites is a require-
ment for full development of a GVL eff  ect. A related issue is 
whether therapeutic induction of local infl  ammation might 
permit the induction of graft-versus-tumor eff  ects outside the 
lymphoid and hematopoietic systems of the host.JEM VOL. 203, August 7, 2006  2029
ARTICLE
MATERIALS AND METHODS
Animals. Animals were used under a protocol approved by our institutional 
Subcommittee on Research Animal Care, and experiments were performed 
in accordance with National Institutes of Health guidelines. Female BALB/cJ, 
C57BL/6, and B6.SJL (CD45.1) mice were purchased from the Frederick 
Cancer Research Facility. Female recipient B6 × DBA/2 (BDF1) mice were 
purchased from Charles River Laboratories. Female donor C57BL/6-trans-
genic (UBC-GFP)30Scha/J mice, which express GFP under the control of 
the human ubiqutin C promoter, were purchased from The Jackson Labora-
tory. 2C T cell receptor transgenic mice (H2b on C57BL/6 background) were 
provided by D. Loh (Washington University, St. Louis, MO). Donors were 
aged 6–13 wk and recipients were aged 11–12 wk at the time of BMT.
BMT, donor leukocyte infusion, and purifi  cation of T cells. MCs 
were established by reconstitution of lethally irradiated recipients with a 
mixture of TCD allogeneic (15 × 106) and host-type (5 × 106) BM cells or 
TCD allogeneic (10–15 × 106) BM cells alone. Recipient mice were lethally 
irradiated (B6 and B6DF1 10.25 Gy, BALB/c 8 Gy, 137Cs source, 0.8 Gy/
min), and TCD BM cells were injected i.v. 4–8 h later. TCD was performed 
using anti-CD4/anti-CD8 microbeads (Miltenyi Biotec). In additional ex-
periments, B6 + BDF1→BDF1 MCs were generated using a nonmyeloab-
lative protocol as described previously (56). MCs were used in experiments 
between 2–3 mo after initial BMT.
Splenocyte suspensions were used for DLIs and were prepared as de-
scribed previously (57). In experiments that involved transfer of activated 
donor T cells derived from freshly irradiated mice, recipients of BMT and 
donor splenocytes were killed on day 4 and splenocytes were harvested. Day 
4 T cells were purifi  ed by passage through nylon wool to remove dead cells 
and then by negative selection to remove non–T cells (pan T isolation kit; 
Miltenyi Biotec). In experiments that involved transfer of activated T cells 
derived from established MCs, DLI recipients were killed on day 12 and 
splenocytes were harvested. Day 12 CD45.1+ T cells were purifi  ed by nega-
tive selection to remove non–T cells (pan T isolation kit; Miltenyi Biotec) 
and then incubated with biotinylated anti-CD45.1 antibody followed by 
positive selection with anti-biotin–conjugated microbeads (Miltenyi Biotec). 
Where required, naive donor 2C CD8+ T cells were isolated (purity >93%) 
by using anti-CD8 microbeads (Miltenyi Biotec) or after activation in vivo 
by negative selection of untouched T cells and positive selection using IgG1 
1B2 clonotypic antibody and anti–mouse IgG1 microbeads (>95% purity). 
In experiments to examine proliferation of transferred donor T cells, poly-
clonal B6 splenocytes and 2C CD8+ T cells were labeled with 1 μM CFSE 
(Invitrogen) as described previously (24). In experiments designed to evalu-
ate the eff  ect of systemic TLR activation, 12.5 μg of the TLR7 agonist 
R-848 was administered by i.p. injection every 72 h for four doses from the 
day of splenocyte transfer to established MCs. In additional experiments, 
1.25 mg imiquimod (3M Pharmaceuticals) was applied to the ear pinnae or 
fl  ank of MCs on days 0 and 5 after splenocyte transfer to MCs.
Assessment of GVHD. Clinical GVHD was assessed by scoring fi  ve pa-
rameters, including hunching, ruffl   ed fur, diarrhea, periorbital edema, and 
activity. Histopathologic analysis of GVHD target organs was performed 
single blind by scoring changes in skin (dermal/epidermal lymphocyte infi  l-
tration, dyskeratotic epidermal keratinocytes, and epidermal thickening) and 
colon (crypt regeneration, apoptosis in crypt epithelial cells, crypt loss, sur-
face colonocyte attenuation, infl  ammatory cell infi  ltration in lamina propria, 
mucosal ulceration, and thickening of mucosa). A severity scale from 0 to 
4 was used: 0, normal; 0.5, focal and rare; 1, focal and mild; 2, diff  use and 
mild; 3, diff  use and moderate; 4, diff  use and severe.
Isolation of lymphocytes from intestines. Mice were killed and per-
fused via the heart with 40 ml PBS containing 10 U/ml heparin. The 
gut, cut longitudinally, was rinsed in cold HBSS, sectioned into 5-mm 
pieces, and shaken at 120 rpm at 37°C for 30 min in RPMI 1640/5% 
FCS. The suspension was then passed serially through a steel mesh, ny-
lon mesh, and nylon wool column before enrichment for lymphocytes by 
density centrifugation (400 g for 30 min) over a Ficoll-Histopaque gradient 
(Sigma-Aldrich).
Flow cytometry. The following antibodies were used: anti–LPAM-1 
(α4β7, DATK32), anti–H2-Dd-biotin (34-2-12), anti–CD4-PE (RM4-5), 
anti–CD8β-PE (H35-17.2), anti–CD11b-PE (M1/70), anti–CD44-FITC 
(IM7), anti–CD45.1-biotin (A20), anti–CD45.2-FITC (104), anti–CD62L-
FITC (MEL-14), anti–rat IgG2a-biotin (RG7/1.30), and all appropriate iso-
type controls (all purchased from BD Biosciences). Detection of biotinylated 
antibodies was performed using either PE or APC linked to streptavidin 
(BD Biosciences). CD8+ T cells bearing the 2C TCR were identifi  ed via the 
clonotype-specifi  c mAb, 1B2, and anti–mouse IgG1-APC (X56; BD Biosci-
ences). Enumeration of CD8+1B2+ T cells in peripheral blood was per-
formed using TRUCOUNT (BD Biosciences) beads according to the 
manufacturer’s instructions.
Quantitative real-time PCR. Methods for RNA extraction, RT, 
  primers/conditions for quantitative PCR, and analysis of quantity values for 
gene expression have been described previously (58). Calculated values for 
the gene of interest were normalized to the housekeeping gene GAPDH.
Intravital two-photon microscopy and fl  ow cytometry. Traffi   cking 
of GFP+ T cells to the skin was imaged noninvasively using a custom-built 
two-photon fl  uorescence microscope designed specifi  cally for in vivo imag-
ing. In brief, output of a femtosecond titanium sapphire laser (890 nm; Co-
herent Mira) was injected into a video rate laser scanning platform consisting 
of a spinning polygon and a galvanometer that steer the laser beam in the fast 
(x) and slow (y) axes, respectively. The laser beam was focused onto the 
sample (mouse ear skin) using a 60×, 1.2NA water immersion objective lens 
(Olympus). Two-photon excited fl  uorescence was collected by the same 
objective lens, separated from the excitation beam by a dichroic fi  lter, and 
detected with a photomultiplier tube (HC-124-2; Hamamamtsu) through 
a band pass fi  lter (500–600 nm; Edmund Optics). Images were acquired at 
30 frames per second and either stored to a digital video recorder or to a 
computer hard drive. In the case of static images, a 1-s frame average was 
performed to improve the signal/noise ratio. Circulating T cells were mea-
sured with an in vivo fl  ow cytometer as described previously (59).
Statistical analysis. Survival data were analyzed using the log-rank test. 
Otherwise, statistical analyses were performed using the Student’s t test or 
the Mann-Whitney test for nonparametric data. A p-value of <0.05 was 
considered to be signifi  cant.
Online supplemental material. Fig. S1 shows survival, clinical, and his-
tological GVHD scores and chimerism after transfer of DLIs to allogeneic 
recipients. Fig. S2 shows expression of CCR7, CXCR3, and α4β7 upon 
CD8+ CTL after transfer to allogeneic recipients. Fig. S3 shows the distribu-
tion of 2C CD8+ T cells after transfer to freshly irradiated BDF1 mice or to 
B6 + BDF1→BDF1 MCs. Video S1 shows traffi   cking of GFP+ donor 
T cells in the ear pinnae of freshly irradiated mice on day 5 after transfer. 
Video S2 shows traffi   cking of GFP+ donor T cells in the ear pinnae of MCs 
on day 5 after transfer.
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